Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Medical Oncology
•
Hematology
•
Sickle Cell
•
Plasma exchange
•
Benign Hematology
•
Hospital Medicine
Would you ever consider depleting alloantibodies using plasma exchange to allow for partially matched RBC exchange in sickle cell patients with critically severe acute chest?
Related Questions
What is your approach to IV fluid resuscitation during a sickle cell vaso-occlusive crisis?
What are your top takeaways in Classical Hematology from ASH 2024?
How would you manage a patient with HbSS and severe pulmonary hypertension on home oxygen?
What is your approach to optimizing pre-operative hemoglobin in patients with sickle cell disease?
What is your standard diagnostic workup to confirm GVHD in a patient post-BMT with skin rash and jaundice?
What adverse events would make you switch off nivo + AVD therapy and to what second line therapy in patients with Hodgkin Lymphoma?
Would you offer TPO-RAs to a steroid-refractory chronic ITP patient with history of stroke?
For women with iron deficiency from heavy uterine bleeding, do you have concerns about the use of NSAIDs for controlling menorrhagia given potential NSAID-induced platelet dysfunction?
What is the optimal timing for PET/CT to assess disease and treatment response with nivo + AVD?
What are your top takeaways from ISTH 2025?
